Latest news headlines from all around the world. Get recent & up-to-date news coverage of all types. Grab top news stories, news headlines for sports, entertainment, business, life style and much more only at Times4News Nation

Thursday, 20 June 2019

U.S. group says Novartis MS drug price out of line with benefit

A U.S. group that reviews the value of medicines issued a critical report on Novartis's new multiple sclerosis drug Mayzent, calling its $88,561 list price "far out of line" compared with its benefits for patients.


from Reuters: U.S. https://reut.rs/2XrWvrS
Share:

Related Posts:

0 comments:

Post a Comment

Copyright © 2025 Times4News Nation - Breaking News, Latest News Business, Technology, Hollywood, Health, Viral... | Powered by Blogger Design by ronangelo | Blogger Theme by NewBloggerThemes.com